MedinCell S.A.
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceuti…
Biotechnology
FR, Jacou [HQ]
MEDCL.PA/Financial Reporting
Income Statements
9 Sheets · Starting from 2015In Million EUR. Margins, Growth Rates In %
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.00 | 8.00 | 6.00 | 1.00 | 2.00 | 8.00 | 4.00 | 9.00 | 9.00 | |
|
EPS
|
0.04 | -0.25 | -0.66 | -1.14 | -1.19 | -0.86 | -1.00 | -1.27 | -0.88 | |
| Diluted in mil. | 0.04 | -0.25 | -0.66 | -1.14 | -1.19 | -0.86 | -1.00 | -1.27 | -0.88 | |
|
Profit
|
7.00 | 7.00 | 6.00 | - - | 1.00 | 6.00 | 8.00 | 13.00 | 9.00 | |
| Gross Margin | 95.97 | 89.63 | 96.61 | 30.08 | 66.02 | 82.27 | 203.86 | 138.08 | 101.42 | |
| Pre Tax | - - | -4.00 | -9.00 | -19.00 | -24.00 | -22.00 | -29.00 | -35.00 | -27.00 | |
| Profit Margin | 4.01 | -57.27 | -143.13 | -1,365.90 | -862.20 | -275.78 | -710.34 | -361.78 | -308.49 | |
| ETR | -77.27 | 27.62 | -3.91 | 0.14 | 2.75 | 15.90 | 14.62 | 10.53 | 10.14 | |
| Net | - - | -3.00 | -9.00 | -19.00 | -23.00 | -18.00 | -24.00 | -32.00 | -25.00 | |
| Profit Margin | 7.56 | -41.73 | -148.66 | -1,364.31 | -838.53 | -231.93 | -606.50 | -323.69 | -277.21 | |
| EBITDA | - - | -2.00 | -6.00 | -15.00 | -21.00 | -17.00 | -26.00 | -26.00 | -18.00 | |
| EBITDA Margin | 9.57 | -25.61 | -99.50 | -1,054.82 | -743.72 | -216.11 | -651.10 | -264.66 | -206.09 | |
| Operating Income | - - | -3.00 | -7.00 | -15.00 | -22.00 | -19.00 | -28.00 | -27.00 | -23.00 | |
| Operating Margin | 5.11 | -42.06 | -114.60 | -1,075.26 | -787.76 | -232.48 | -688.17 | -281.49 | -264.09 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Loss | -7.00 | -11.00 | -13.00 | -16.00 | -25.00 | -27.00 | -32.00 | -37.00 | -32.00 | |
| Cost of Revenue | - - | - - | - - | -1.00 | - - | -1.00 | -4.00 | -3.00 | - - | |
|
Operating Expenses
|
-7.00 | -10.00 | -13.00 | -15.00 | -24.00 | -25.00 | -30.00 | -36.00 | -32.00 | |
| R&D | -5.00 | -7.00 | -8.00 | -11.00 | -16.00 | -18.00 | -22.00 | -26.00 | -21.00 | |
| G&A | -2.00 | -2.00 | -4.00 | -4.00 | -5.00 | -5.00 | -6.00 | -7.00 | - - | |
| SG&A | -2.00 | -4.00 | -6.00 | -7.00 | -7.00 | -7.00 | -8.00 | -9.00 | -11.00 | |
| S&M | - - | -1.00 | -1.00 | -2.00 | -2.00 | -1.00 | -2.00 | -2.00 | - - | |
| Depreciation and Amortization | - - | - - | - - | - - | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | |
| Interest Expenses | - - | -1.00 | -1.00 | -2.00 | -2.00 | -3.00 | -1.00 | -3.00 | -4.00 | |
| Other Expenses | - - | -2.00 | -1.00 | -4.00 | -2.00 | -3.00 | - - | -7.00 | -4.00 | |
|
WA Shares Outstanding
|
14.00 | 14.00 | 14.00 | 17.00 | 20.00 | 22.00 | 24.00 | 25.00 | 28.00 | |
| Diluted | 14.00 | 14.00 | 14.00 | 17.00 | 20.00 | 22.00 | 24.00 | 25.00 | 28.00 |